Entchev, E., Jantzen, I., Masson, P., Bocart, S., Bournique, B., Luccarini, J., . . . Tallandier, M. (2020). Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models. PloS one, 15(5), e0233032. https://doi.org/10.1371/journal.pone.0233032
Citace podle Chicago (17th ed.)Entchev, Eugeni, et al. "Odiparcil, a Potential Glycosaminoglycans Clearance Therapy in Mucopolysaccharidosis VI—Evidence from in Vitro and in Vivo Models." PloS One 15, no. 5 (2020): e0233032. https://doi.org/10.1371/journal.pone.0233032.
Citace podle MLA (9th ed.)Entchev, Eugeni, et al. "Odiparcil, a Potential Glycosaminoglycans Clearance Therapy in Mucopolysaccharidosis VI—Evidence from in Vitro and in Vivo Models." PloS One, vol. 15, no. 5, 2020, p. e0233032, https://doi.org/10.1371/journal.pone.0233032.